Shionogi & Co., Ltd. (OTCMKTS:SGIOF – Get Free Report) shot up 15.6% during trading on Monday . The stock traded as high as $14.19 and last traded at $14.19. 120 shares were traded during mid-day trading, a decline of 54% from the average session volume of 260 shares. The stock had previously closed at $12.28.
Shionogi & Co., Ltd. Price Performance
The business has a fifty day moving average of $12.91 and a 200 day moving average of $24.99.
Shionogi & Co., Ltd. Company Profile
Shionogi & Co, Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan. It offers Fetroja, a multidrug-resistant for gram-negative bacterial infection treatment; Cabenuva and Apretude an anti-HIV and HIV prophylactic drug; Xocova an oral COVID-19 treatment drug; Finibax a carbapenem antibiotic; Xofluza, an influenza antiviral drug; and Tivicay, an anti-HIV drug.
See Also
- Five stocks we like better than Shionogi & Co., Ltd.
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- How to Short Sell Stocks Like a Pro: Strategies and Tips
- Low PE Growth Stocks: Unlocking Investment Opportunities
- 3 Steel Stocks Soaring After Tariff Announcements
- 3 Warren Buffett Stocks to Buy Now
- Top Analysts’ Picks for 2025: 3 of Morgan Stanley’s Favorites
Receive News & Ratings for Shionogi & Co. Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shionogi & Co. Ltd. and related companies with MarketBeat.com's FREE daily email newsletter.
